Partnerships

Zylö Therapeutics is committed to leveraging its innovative Nanopod™ sustained-release drug-delivery platform by working with partners across the Rx-OTC-cosmeceutical spectrum to develop and commercialize unique therapies that address unmet clinical needs.

We are seeking regional or global development partners that are interested in evaluating:

cannabis-releasing Nanopods™ for the treatment of chronic pain, skin manifestations of lupus, muscle spasms, or other indications

our paramagnetic Nanopods™ for the targeted treatment of cancers or other conditions requiring targeted therapy

our paramagnetic Nanopods™ for the treatment of ischemia reperfusion injury or other conditions requiring targeted therapy

Nanopods™ that release one or more of the following for any number of possible Rx/OTC/cosmeceutical applications: Lidocaine, Nitric Oxide, curcumin, quercetin, allicin, Vitamin A, Vitamin C, Vitamin E, melanin